PURPLE BIOTECH LTD. (PPBT)

Every figure this model derived for PPBT, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2020-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities 2025-12-31
cash 10,717,000 CashAndCashEquivalents 2025-12-31
current assets 9,866,000 CurrentAssets 2025-12-31
current liabilities 7,753,000 CurrentLiabilities 2025-12-31
equity 9,714,000 EquityAttributableToOwnersOfParent 2025-12-31
revenue 1,000,000 Revenue 2020-12-31
sbc 0 AdjustmentsForSharebasedPayments 2025-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up PPBT on one particular measure came for.

RatioValue
current ratio1.27
current ratio reported1.27
growth cv1.41
revenue growth0.0
revenue growth per share0.0
sbc pct revenue0.0

What to be careful about

What this model itself distrusts about PPBT's figures. Written by the derivation as it ran, not added afterwards.